Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Europlan starts collecting applications for participation in the IPO

3/22/24 LEAS

Samolet Group will develop the left-bank part of Rostov-on-Don

3/22/24 SMLT

Bank of Russia is working on the possibility of direct investor access to the stock exchange

3/22/24 MOEX

Mikron launched two new production lines

3/22/24 AFKS

M.Video created a microfinance organization

3/22/24 MVID

Segezha reported for 2023 by IFRS

3/22/24 SGZH

Binnopharm Group reported for 2023 by IFRS

3/22/24 AFKS

Gazprom has started connecting Power of Siberia to Sakhalin - Khabarovsk - Vladivostok

3/22/24 GAZP

Cristal and Germany's Mast-Jägermeister SE entered into a settlement agreement

3/21/24 KLVZ

Bank of Russia approved a 100-to-1 split of Nornickel shares

3/21/24 GMKN